Scientists hunt for clues to predict radiation injury in cancer patients
NCT ID NCT07528287
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study aims to identify biological markers that could predict radiation-induced intestinal injury in people receiving abdominal radiotherapy. Researchers will observe 220 adult patients who are about to start high-dose radiation. By analyzing samples and outcomes, they hope to build a model that forecasts who might develop gut damage from treatment.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a predictive model that helps doctors identify patients at risk for radiation-induced intestinal injury before symptoms appear.
- What could go wrong
- This is an observational study, not a treatment trial. It may not find reliable biomarkers, and any predictive model would need further validation before clinical use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 220 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Apr 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2031
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients with malignant tumors undergoing abdominal radiotherapy that may involve the intestine
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Abdominal radiotherapy dose ≥45 Gy; 2. Age ≥18 years; 3. Karnofsky Performance Status (KPS) \>60; 4. Expected survival \>6 months. Exclusion Criteria: 1. Prior history of abdominal radiotherapy; 2. Active intestinal infection; 3. Intestinal inflammatory diseases due to other causes; 4. Inability to provide biological samples.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Radiation-induced intestinal injury are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.